Disease ID | Disease name | Source of annotation with PTGIS | OMIM link | Number of associated genes | genes |
---|---|---|---|---|---|
145500 | HYPERTENSION, ESSENTIAL | ClinVar, OMIM | link to OMIM | 13 | RGS5, PTGIS, ADD1, NOS3, UMOD, AGT, ECE1, CYP3A5, ATP1B1, NOS2, GNB3, AGTR1, SELE |
Download the gene annotation in CSV format
KEGG pathway | KEGG ID | KEGG IC |
---|---|---|
Arachidonic acid metabolism | hsa00590 | 6.79 |
Metabolic pathways | hsa01100 | 2.49 |
REACTOME pathway | REACTOME ID | REACTOME IC |
---|---|---|
Nicotinamide salvaging | R-HSA-197264 | 10.66 |
Bile acid and bile salt metabolism | R-HSA-194068 | 7.85 |
Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 6.54 |
Sterols are 12-hydroxylated by CYP8B1 | R-HSA-211994 | 11.98 |
Nicotinate metabolism | R-HSA-196807 | 9.52 |
Biological oxidations | R-HSA-211859 | 5.55 |
Metabolism of vitamins and cofactors | R-HSA-196854 | 6.54 |
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 8.4 |
Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 7.08 |
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.18 |
Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.08 |
Phase 1 - Functionalization of compounds | R-HSA-211945 | 6.7 |
Metabolism | R-HSA-1430728 | 2.34 |
Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.18 |
Synthesis of bile acids and bile salts | R-HSA-192105 | 8.23 |
Arachidonic acid metabolism | R-HSA-2142753 | 7.34 |
Metabolism of lipids and lipoproteins | R-HSA-556833 | 3.79 |
Endogenous sterols | R-HSA-211976 | 8.46 |
Eicosanoids | R-HSA-211979 | 9.4 |
GO term | GO ID | GO IC |
---|---|---|
cation binding | GO:0043169 | 1.4 |
monooxygenase activity | GO:0004497 | 5.1 |
metal ion binding | GO:0046872 | 1.41 |
heme binding | GO:0020037 | 4.86 |
transition metal ion binding | GO:0046914 | 2.48 |
isomerase activity | GO:0016853 | 4.62 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | GO:0016705 | 4.65 |
organic cyclic compound binding | GO:0097159 | 1.05 |
tetrapyrrole binding | GO:0046906 | 4.8 |
ion binding | GO:0043167 | 1.36 |
catalytic activity | GO:0003824 | 1.05 |
binding | GO:0005488 | 0.18 |
protein binding | GO:0005515 | 0.46 |
prostaglandin-I synthase activity | GO:0008116 | 9.74 |
iron ion binding | GO:0005506 | 4.65 |
oxidoreductase activity | GO:0016491 | 3.12 |
heterocyclic compound binding | GO:1901363 | 1.06 |
intramolecular oxidoreductase activity | GO:0016860 | 5.75 |